Clinical trial
Use of APT™ T3X to Decrease the COVID-19 Contamination Rate in Humans
NCT04716426 is registered in ClinicalTrials.gov with University of Nove de Julho as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of APT™ T3X to Decrease the COVID-19 Contamination Rate in Humans
- Lead sponsor
- University of Nove de Julho
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 28, 2021
- Completion date
- March 25, 2021
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.